Detalhe da pesquisa
1.
Role of KCNK3 Dysfunction in Dasatinib-associated PAH and Endothelial Cell Dysfunction.
Am J Respir Cell Mol Biol
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38546978
2.
Orai1 Inhibitors as Potential Treatments for Pulmonary Arterial Hypertension.
Circ Res
; 131(9): e102-e119, 2022 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36164973
3.
Contribution of transient receptor potential canonical channels in human and experimental pulmonary arterial hypertension.
Am J Physiol Lung Cell Mol Physiol
; 325(2): L246-L261, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37366608
4.
SUR1 As a New Therapeutic Target for Pulmonary Arterial Hypertension.
Am J Respir Cell Mol Biol
; 66(5): 539-554, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35175177
5.
Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension.
Eur Respir J
; 58(5)2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33926975
6.
In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression.
Respir Res
; 21(1): 186, 2020 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32678044
7.
Proteomic Analysis of KCNK3 Loss of Expression Identified Dysregulated Pathways in Pulmonary Vascular Cells.
Int J Mol Sci
; 21(19)2020 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33036472
8.
Comment on: Transcriptomic analysis of CFTR-impaired endothelial cells reveals a pro-inflammatory phenotype.
Eur Respir J
; 58(2)2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34413125
9.
Pulmonary hypertension associated with diazoxide: the SUR1 paradox.
ERJ Open Res
; 9(6)2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37965230
10.
Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension.
Biomolecules
; 12(4)2022 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35454073
11.
Involvement of SUR2/Kir6.1 channel in the physiopathology of pulmonary arterial hypertension.
Front Cardiovasc Med
; 9: 1066047, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36704469
12.
Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension.
Biomolecules
; 10(9)2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32882918
13.
The Experimental TASK-1 Potassium Channel Inhibitor A293 Can Be Employed for Rhythm Control of Persistent Atrial Fibrillation in a Translational Large Animal Model.
Front Physiol
; 12: 668267, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33912077